Maiolo, Elena
 Distribuzione geografica
Continente #
EU - Europa 1.397
NA - Nord America 1.383
AS - Asia 929
SA - Sud America 169
AF - Africa 34
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.924
Nazione #
US - Stati Uniti d'America 1.326
DE - Germania 492
SG - Singapore 438
CN - Cina 263
PL - Polonia 191
IT - Italia 184
SE - Svezia 177
BR - Brasile 141
GB - Regno Unito 86
FR - Francia 78
IN - India 54
VN - Vietnam 47
FI - Finlandia 38
CA - Canada 35
IE - Irlanda 32
UA - Ucraina 32
ID - Indonesia 25
RU - Federazione Russa 19
TR - Turchia 19
MX - Messico 15
AT - Austria 11
JP - Giappone 11
CI - Costa d'Avorio 10
AU - Australia 9
NL - Olanda 8
AR - Argentina 7
BE - Belgio 7
IL - Israele 7
IQ - Iraq 7
KR - Corea 7
ZA - Sudafrica 7
BD - Bangladesh 6
HK - Hong Kong 6
IR - Iran 6
LT - Lituania 6
PY - Paraguay 6
ES - Italia 5
RO - Romania 5
TN - Tunisia 5
CH - Svizzera 4
CZ - Repubblica Ceca 4
MY - Malesia 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
AZ - Azerbaigian 3
CL - Cile 3
DK - Danimarca 3
EC - Ecuador 3
EG - Egitto 3
GR - Grecia 3
MA - Marocco 3
PE - Perù 3
PK - Pakistan 3
UY - Uruguay 3
BG - Bulgaria 2
CG - Congo 2
CY - Cipro 2
HN - Honduras 2
JM - Giamaica 2
JO - Giordania 2
KE - Kenya 2
KG - Kirghizistan 2
KW - Kuwait 2
LB - Libano 2
SA - Arabia Saudita 2
TT - Trinidad e Tobago 2
UZ - Uzbekistan 2
VE - Venezuela 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
BY - Bielorussia 1
CO - Colombia 1
DZ - Algeria 1
EE - Estonia 1
EU - Europa 1
GE - Georgia 1
HU - Ungheria 1
LV - Lettonia 1
NG - Nigeria 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PT - Portogallo 1
PW - Palau 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TW - Taiwan 1
Totale 3.924
Città #
Singapore 262
Warsaw 182
Chandler 167
Ashburn 152
Fairfield 97
Beijing 65
Rome 52
New York 49
Munich 48
Houston 47
Woodbridge 43
Seattle 41
Wilmington 38
Los Angeles 37
Ann Arbor 35
Dallas 32
Dublin 32
Hefei 32
Nürnberg 32
San Mateo 29
Jacksonville 26
Nanjing 25
Jakarta 23
The Dalles 23
Frankfurt am Main 21
Helsinki 20
Cambridge 19
Dearborn 18
Bremen 16
Hyderabad 15
London 15
Milan 15
Boston 14
Buffalo 14
Chicago 14
Cattolica 13
Ho Chi Minh City 13
Moscow 13
Hanoi 12
Marseille 11
Princeton 11
Abidjan 10
Redwood City 10
São Paulo 10
Fremont 9
Kent 9
Mexico City 9
Montreal 9
Nuremberg 9
Nanchang 8
Stockholm 8
Turku 8
Wroclaw 8
Brooklyn 7
Brussels 7
Izmir 7
Orem 7
Poplar 7
Redmond 7
Seoul 7
Toronto 7
Belo Horizonte 6
Guangzhou 6
Hangzhou 6
Kunming 6
Lauterbourg 6
Phoenix 6
San Francisco 6
San Jose 6
Shanghai 6
Tokyo 6
Vienna 6
Amsterdam 5
Asunción 5
Haiphong 5
Hong Kong 5
Johannesburg 5
Kish 5
Kocaeli 5
Lancaster 5
Lappeenranta 5
Lawrence 5
Roubaix 5
Santa Clara 5
Tianjin 5
Ankara 4
Atlanta 4
Changsha 4
Chennai 4
Düsseldorf 4
Falls Church 4
Livorno 4
Manchester 4
Norwalk 4
Osasco 4
Paris 4
Romainville 4
Andover 3
Araraquara 3
Baku 3
Totale 2.174
Nome #
HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION IN FIRST LINE TREATMENT FOR HIGH-RISK DIFFUSE LARGE B CELL LYMPHOMA (DLBCL) IN THE RITUXIMAB ERA: AN INTENTION TO TREAT-ANALYSIS 402
Vitamin D deficiency and supplementation in patients with aggressive B-cell lymphomas treated with immunochemotherapy 320
Risk factors for venous thromboembolism in patients with lymphoma requiring hospitalization 315
THE PROGNOSTIC ROLE OF EBV IN PERIPHERAL BLOOD OF PATIENTS WITH DIFFUSE LARGE B CELL LYMPHOMA 272
Quantification of DAPK1 Promoter Methylation in Bone Marrow and Peripheral Blood as a Follicular Lymphoma Biomarker 260
Venous Thromboembolism in Lymphoma: Risk Stratification and Antithrombotic Prophylaxis 216
Anemia in Diffuse Large B cell Non-Hodgkin Lymphoma: The Role of IL-6, Hepcidin and Erythropoietin 202
Progressive multifocal leukoencephalopathy in patients with follicular lymphoma treated with bendamustine plus rituximab followed by rituximab maintenance 159
Progressive multifocal leukoencephalopathy in patients with follicular lymphoma treated with bendamustine plus rituximab followed by rituximab maintenance 151
Whole blood EBV-DNA predicts outcome in diffuse large B-cell lymphoma 145
Management of the kidney transplant patient with Cancer: Report from a Multidisciplinary Consensus Conference 133
Anemia in diffuse large B-cell non-Hodgkin lymphoma: the role of interleukin-6, hepcidin and erythropoietin. 125
Novel Targets and Advanced Therapies in Diffuse Large B Cell Lymphomas 124
Enhancing lymphoma diagnosis on core needle biopsies: Integrating immunohistochemistry with flow cytometry 115
Comorbidity assessment to determine prognosis in older adult patients with classical Hodgkin lymphoma 115
The prognostic impact of monoclonal immune globulin and free light chain secretion in diffuse large B cell lymphoma (DLBCL) 114
Four doses of unpegylated versus one dose of pegylated filgrastim as supportive therapy in R-CHOP-14 for elderly patients with diffuse large B-cell lymphoma 109
Predicting time to treatment in follicular lymphoma on watchful waiting using baseline metabolic tumour burden 98
Severe cmv infection after chemo-immunotherapy with dose- reduced bendamustine and rituximab in a mantle cell lymphoma old patient 98
Acute erythroid leukemia with TP53 mutation and BCR/ABL1: challenges in classification and management 87
Safety and efficacy of SARS-Cov2 neutralizing monoclonal antibodies after stem cell transplant or CAR-T cell infusion 82
The CD4/CD8 ratio of infused CD19-CAR-T is a prognostic factor for efficacy and toxicity 77
Endoscopic Ultrasound-Guided Fine Needle Biopsy in the Diagnostic Work-Up of Deep-Seated Lymphadenopathies and Spleen Lesions: A Monocentric Experience 76
Hematopoiesis and immune reconstitution after CD19 directed chimeric antigen receptor T‐cells (CAR‐T): A comprehensive review on incidence, risk factors and current management 64
Epstein-Barr Virus (EBV)-Associated Haemophagocytic Syndrome 38
Treatment outcomes in elderly patients ≥ 65 years with Large B-Cell Lymphoma (LBCL): a real-world single center experience focusing on potential CD19-CAR-T eligibility in second line 36
The predictive power of 18F-FDG PET/CT two-lesions radiomics and conventional models in classical Hodgkin’s Lymphoma: a comparative retrospectively-validated study 14
Safety and efficacy of SARS-Cov2 neutralizing monoclonal antibodies after stem cell transplant or CAR-T cell infusion 13
Baseline 18F-FDG PET/CT Radiomics in Classical Hodgkin’s Lymphoma: The Predictive Role of the Largest and the Hottest Lesions 9
Heterogeneous Surface CD79b Expression in Aggressive B-Cell Lymphomas Assessed by Flow Cytometry on Lymph Node Biopsies 9
B-cell Receptor Silencing Reveals the Origin and Dependencies of High-Grade B-cell Lymphomas with MYC and BCL2 Rearrangements 9
The Impact of Radiotherapy and Attenuated Chemotherapy Regimens in Older Patients with Classic Hodgkin Lymphoma: A Real-Life Study from the ReLLi Network 7
Totale 3.994
Categoria #
all - tutte 14.019
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.019


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021202 0 0 0 0 0 26 19 16 15 29 79 18
2021/2022267 36 22 5 6 21 5 17 32 22 26 39 36
2022/2023467 68 59 24 92 21 49 31 46 47 6 14 10
2023/2024277 4 68 8 16 8 51 8 43 2 1 28 40
2024/2025703 28 24 52 38 65 30 46 19 68 71 136 126
2025/2026918 193 59 101 176 335 54 0 0 0 0 0 0
Totale 3.994